Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis Joachim Burman, Anders Svenningsson Journal of Neuroimmunology Volume 292, Pages 40-44 (March 2016) DOI: 10.1016/j.jneuroim.2016.01.008 Copyright © 2016 Elsevier B.V. Terms and Conditions
Fig. 1 Concentrations of Galectin-9 in two independent cohorts. (A) Levels of Galectin-9 in healthy controls and patients with different subtypes of MS from cohort A. (B) Levels of Galectin-9 in healthy controls and patients with different subtypes of MS from cohort B. (C) Levels of Galectin-9 in untreated vs treated RRMS patients from cohort B. (D) Galectin-9 concentrations from the combined cohorts (medians with interquartile range). Journal of Neuroimmunology 2016 292, 40-44DOI: (10.1016/j.jneuroim.2016.01.008) Copyright © 2016 Elsevier B.V. Terms and Conditions